Power Rolloff During Interactive Radiofrequency Ablation Can Enhance Necrosis When Treating Hepatocellular CarcinomaShi-Ming Lin, Cheng‐Yuan Peng, Chun‐Jung Lin et al.|American Journal of Roentgenology|2003Cited by 28
Phase IV randomized clinical study: Peginterferon alfa-2a with adefovir or entecavir pre-therapy for HBeAg-positive chronic hepatitis BChao‐Wei Hsu, Yun‐Fan Liaw, Wei‐Wen Su et al.|Journal of the Formosan Medical Association|2018Cited by 26
Ropeginterferon alfa‐2b in patients with genotype 1 chronic hepatitis C: Pharmacokinetics, safety, and preliminary efficacyHsien Hong Lin, Pei‐Jer Chen, Shih Jer Hsu et al.|JGH Open|2021Cited by 22
Ropeginterferon Alfa-2b administered every two weeks for patients with genotype 2 chronic hepatitis CShih-Jer Hsu, Wan‐Long Chuang, Rong‐Nan Chien et al.|Journal of the Formosan Medical Association|2020Cited by 22
Drug‐induced liver injury associated with severe cutaneous adverse drug reactions: A nationwide study in TaiwanYi‐Shin Huang, Chen‐Yi Wu, Ting‐Tsung Chang et al.|Liver International|2021Cited by 21